Skip to content
UniqueBaseEN
For AI ↗
Companies

Weiyuan Biotechnology

Transliterated name · original name retained below

Visit website ↗
Snapshot

As of Oct 15, 2026, UniqueBase lists 1 funding record for Weiyuan Biotechnology; the latest is RMB 100M (Pre-Series A) on Aug 19, 2025.

Funding records
1
Latest round
RMB 100M · Pre-Series A
Total raised (reported)
—
Rows with a source link
0 of 1

Overview

Weiyuan Biotechnology is a company headquartered in Hangzhou, China, founded in 2023.

Summary generated from the structured facts on this page.

Funding · 1

Funding

Amounts as reported; USD estimates shown only when they match

Listed 1 funding record. Latest funding: RMB 100M (Pre-Series A), Aug 19, 2025.

Annual trendUnit: USD
2025$14MAug 19, 2025: $14M · Pre-Series A
DateAmountInvestorsSources
Aug 19, 2025RMB 100M ≈ $14.3M · Pre-Series A大晶创投, 熔拓资本, 硅谷真石, 道彤投资 No source link

Select ▸ on a row to see its source brief and links.

Valuation · 1

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 1 valuation record.

Annual trendUnit: USD

No chartable valuation estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Aug 19, 2025— · Pre-Series A大晶创投, 熔拓资本, 硅谷真石, 道彤投资 No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

Team, products & investors

Explore

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.